Scientific deep-dive
Why Am I Always Cold on a GLP-1? (Cold Intolerance)
Feeling cold on Wegovy or Zepbound is mostly the weight-loss state — lost insulation, lower thermogenesis, metabolic adaptation. Plus thyroid/iron red flags.
If you have started feeling cold all the time on Wegovy, Zepbound, Mounjaro, or Saxenda — reaching for an extra layer, cold hands and feet, shivering in a room that never used to bother you — you are noticing something real, and there is a clean mechanistic explanation for most of it. Feeling colder on a GLP-1 is, in the large majority of cases, a signal of the rapid weight-loss and reduced-calorie state itself, not a direct pharmacological effect of the drug on your thermostat. Losing fat removes insulation, eating less lowers the heat your metabolism produces, and your body deliberately turns down its resting energy expenditure to defend against the deficit. This article walks through each mechanism with primary-source citations, then flags the specific situations where cold intolerance is worth a thyroid or iron check rather than reassurance.
About this article
Every clinical claim below is sourced from the primary PubMed-indexed literature cited in our References section, or from the pivotal GLP-1 weight-management trials (STEP-1 for semaglutide, SURMOUNT-1 for tirzepatide). Each PMID was confirmed by direct lookup against the live PubMed E-utilities API. This article is educational and is not medical advice. Do not start, stop, or change any medication, and do not self-diagnose a thyroid or iron problem, without speaking to a licensed clinician who knows your full history. For the closely related topic of low energy, see our companion deep-dive on why GLP-1 medications cause fatigue and how to manage it.
TL;DR — feeling cold is mostly the weight-loss state, not the drug
Cold intolerance on a GLP-1 medication is common, and in most people it tracks the things that change when you lose weight quickly while eating much less: you carry less insulating body fat, your body produces less heat because it is processing far fewer calories, and your metabolism adaptively downshifts to conserve energy. None of these require a direct effect of semaglutide or tirzepatide on your core temperature set point — they are predictable consequences of a large, sustained energy deficit and meaningful fat loss. The reassuring news is that this is a well-described physiology of weight loss in general, documented long before GLP-1 drugs existed.
- Less insulation — body fat is an insulator; losing it makes you feel cold faster, especially in the hands, feet, and skin.
- Less heat from food — a large share of daily heat production comes from digesting and metabolizing meals (diet-induced thermogenesis); eat much less and you generate less of it.
- Metabolic adaptation — the body lowers resting energy expenditure beyond what fat loss alone predicts, which means less baseline heat output.
- Possible muscle loss — some weight lost on any rapid-deficit plan is lean mass, and muscle is metabolically active heat-producing tissue.
- The red-flag exception — cold intolerance with fatigue, hair changes, constipation, or pallor can also point to an underactive thyroid or iron-deficiency anemia, which deserve a lab check.
Mechanism 1 — losing fat removes your insulation
Subcutaneous body fat is a physical thermal insulator. The layer of fat beneath the skin slows heat loss from the warm body core to the cooler environment — which is exactly why people with more of it tolerate cold more comfortably and why lean individuals chill faster in the same room. When you lose a meaningful amount of fat on a GLP-1 medication, you are, quite literally, removing part of the insulating shell that kept warmth in. The effect shows up earliest in the extremities — cold hands and feet — because the body preferentially diverts blood flow away from the periphery to defend core temperature when it senses heat loss.
This is not a small amount of weight in trial populations. In STEP-1, adults on semaglutide 2.4 mg lost a mean of roughly 15% of body weight over 68 weeks, and in SURMOUNT-1, tirzepatide at the top dose produced mean weight loss of about 21% over 72 weeks. A reduction of that magnitude meaningfully thins the insulating fat layer, and feeling colder is a logical downstream consequence rather than a mysterious drug side effect.
Mechanism 2 — eating much less means producing less heat
A substantial fraction of the heat your body produces every day comes from processing food. This is called diet-induced thermogenesis (the thermic effect of food): the energy cost of digesting, absorbing, and metabolizing a meal is released largely as heat, and it accounts for roughly 10% of total daily energy expenditure in people eating a normal mixed diet. GLP-1 receptor agonists work primarily by sharply reducing appetite and food intake — so when intake falls steeply, the heat generated by metabolizing meals falls with it. Fewer meals, smaller meals, and longer gaps between eating all mean fewer of these thermogenic pulses across the day, which can leave you feeling cooler, particularly in the hours between meals.
The protein component of diet-induced thermogenesis matters here in a practical way: protein has the highest thermic effect of any macronutrient, so when overall intake collapses, the heat-generating contribution of food drops further. This is one reason the comfort tips later in this article emphasize keeping protein in the meals you do eat. The broader picture of how GLP-1 medications change daily energy output — including the brown-fat and resting-metabolism angle — is covered in our companion review of GLP-1 effects on metabolism, energy expenditure, and brown fat.
Mechanism 3 — metabolic adaptation turns the furnace down
When you lose weight, your resting metabolic rate falls — and it falls by more than body-size change alone would predict. This phenomenon, called adaptive thermogenesis or metabolic adaptation, was characterized in classic human work by Leibel and colleagues, who showed that maintaining a reduced body weight lowers total and resting energy expenditure beyond the amount explained by the loss of tissue. Your body, in effect, learns to run on fewer calories — which is energy-efficient for surviving a deficit but also means it is generating less metabolic heat at rest.
Just how persistent this can be was illustrated by the long-term follow-up of "The Biggest Loser" competitors, in whom resting metabolic rate remained substantially suppressed years after the weight loss. And in tightly controlled human calorie-restriction studies, this downshift is measurable as a genuinely lower body temperature: in the CALERIE pilot, six months of sustained calorie restriction produced a small but real reduction in core body temperature alongside the drop in metabolic rate. A lower resting metabolic rate and a slightly cooler core temperature are two sides of the same adaptive coin — and both make you feel the cold more. Because GLP-1 medications drive weight loss largely by enforcing a calorie deficit, this is the most direct explanation for persistent cold intolerance in someone who is eating far less than before. The flip side — when the deficit becomes too aggressive — is covered in our review of eating too little on a GLP-1.
Mechanism 4 — some of the weight lost is muscle
Not all of the weight lost on a rapid calorie deficit is fat. A systematic review of significant weight loss found that fat-free mass — which is mostly skeletal muscle — typically accounts for a meaningful share of total weight lost, often around a quarter, depending on the rate of loss, baseline body composition, protein intake, and exercise. This matters for temperature because skeletal muscle is metabolically active, heat-producing tissue: it contributes to resting metabolic rate, and shivering thermogenesis (the involuntary muscle contractions that warm you when cold) depends on having muscle to recruit. Losing lean mass therefore subtracts from your baseline heat output and from your capacity to warm yourself back up.
The practical lever you control
Muscle loss during weight loss is not fixed — it is heavily modifiable by adequate protein intake and resistance training. Preserving lean mass not only protects your metabolic rate and strength, it also protects your capacity to generate and retain heat. Prioritizing protein at each meal and adding resistance exercise are among the few cold-relevant interventions fully within your control while on a GLP-1.
Is it the drug itself? An honest answer
It is worth being direct: cold intolerance is not a prominently listed adverse reaction tied to a specific thermoregulatory action of semaglutide or tirzepatide the way nausea or fatigue are. The weight of the evidence points to the weight-loss and under-eating state — reduced insulation, reduced diet-induced thermogenesis, metabolic adaptation, and lean-mass changes — as the driver, rather than a direct effect of the molecule on your hypothalamic thermostat. That distinction is reassuring, because it means feeling cold is a predictable consequence of successful weight loss and tends to be most noticeable during active, rapid loss, often easing as weight stabilizes and intake normalizes at the new set point. It also means the most effective responses are the same sensible measures that support healthy weight loss generally: enough protein, enough food overall, resistance training, and patience while your body adapts.
When cold intolerance warrants a thyroid or iron check
Most cold intolerance on a GLP-1 is benign physiology — but cold intolerance is also a classic symptom of two conditions that are common, treatable, and easy to miss in the context of weight loss: an underactive thyroid (hypothyroidism) and iron-deficiency anemia. Both can independently impair the body's ability to generate and regulate heat. In fact, iron deficiency and thyroid function are physiologically linked — impaired thermoregulation has been demonstrated in iron-deficiency anemia together with altered thyroid hormone handling. Because the symptoms overlap so heavily with the weight-loss state, the only reliable way to tell them apart is laboratory testing.
Get labs checked if cold intolerance comes with these
Ask your clinician about a thyroid panel (TSH, often free T4) and an iron and complete blood count (ferritin, hemoglobin) if your feeling-cold is accompanied by any of: persistent fatigue out of proportion to your deficit, unexplained hair thinning or loss, dry skin, constipation, a slow heart rate, hoarseness, facial puffiness, low mood, or pale skin, brittle nails, shortness of breath, dizziness, or pica (craving ice). These point toward hypothyroidism or iron-deficiency anemia rather than ordinary weight-loss chilliness, and both are readily treatable once identified. This is general information, not a diagnosis — your clinician interprets the labs in your context.
There is one extra wrinkle worth knowing if you already take thyroid medication: GLP-1 drugs slow gastric emptying, which can change how some oral medications are absorbed, including levothyroxine. If you are on thyroid hormone replacement and notice new cold intolerance, do not adjust your dose on your own — review timing and monitoring with your prescriber. We cover this interaction in detail in our piece on levothyroxine and GLP-1 absorption, and the broader topic of thyroid lab monitoring in our guide to TSH monitoring on GLP-1 therapy. For the iron and anemia side, see our review of iron deficiency, anemia, and ferritin on GLP-1 medications.
Practical comfort tips
Most of the following are aimed at the underlying drivers — preserving heat-producing tissue, keeping food (and therefore diet-induced thermogenesis) in your day, and managing heat loss directly. None of them are a substitute for a lab check if you have the red-flag symptoms above.
- Prioritize protein at every meal. Protein both has the highest thermic effect of any macronutrient and supports lean-mass preservation — two of the four cold mechanisms at once. Aim for a protein source at each meal even when appetite is low.
- Do not under-eat the whole day. Eating too little drives metabolic adaptation harder and removes the thermogenic pulses of meals. Spreading modest, regular meals across the day produces more steady heat than one tiny meal.
- Add resistance training. Building or maintaining muscle protects your resting metabolic rate, your strength, and your shivering capacity. It is the most controllable lever you have.
- Dress in layers and warm the extremities. Because the body sacrifices the hands and feet first, warm socks, gloves, and a hat disproportionately improve comfort relative to the effort.
- Use warm drinks and warm food. Hot beverages and warm meals add direct heat and a small thermogenic boost — and warm fluids also support the hydration that is easy to neglect when appetite is suppressed.
- Move regularly. Light activity throughout the day generates heat and improves peripheral circulation, countering the cold-hands-and-feet pattern.
- Mind the bedroom and showers. A slightly warmer sleep environment and warm showers help during the active-loss phase when you are most sensitive.
- Track for red flags. If chilliness is worsening or pairs with the thyroid or anemia symptoms above, book the lab check rather than just adding another layer.
Frequently asked questions
Why am I always cold on Wegovy or Zepbound?
In most people it is the weight-loss and reduced-calorie state, not a direct drug effect. Losing fat removes insulation, eating much less reduces the heat your body produces from digesting food (diet-induced thermogenesis), your metabolism adaptively lowers its resting heat output, and some of the weight lost is heat-producing muscle. All four push you toward feeling colder, and they are predictable consequences of rapid weight loss rather than a specific thermoregulatory action of semaglutide or tirzepatide.
Does a GLP-1 directly lower my body temperature?
There is no prominent evidence that semaglutide or tirzepatide directly resets your core thermostat the way a fever-causing illness does. What does lower body temperature is sustained calorie restriction itself: in tightly controlled human studies, six months of calorie restriction produced a small but measurable drop in core body temperature alongside reduced metabolic rate. Because GLP-1 drugs cause weight loss by enforcing a calorie deficit, that restriction-driven cooling is the more accurate explanation than a direct drug effect.
Will feeling cold go away?
For most people it eases as weight loss slows and intake stabilizes at a new set point — cold intolerance tends to be most noticeable during active, rapid loss. Preserving muscle with protein and resistance training, and not under-eating, all help. If chilliness persists or worsens after your weight has stabilized, that is a reason to look for a thyroid or iron cause rather than assuming it is just the diet.
When should cold intolerance make me see a doctor?
See your clinician for a thyroid panel (TSH) and iron studies (ferritin, hemoglobin, complete blood count) if feeling cold comes with fatigue out of proportion to your deficit, hair thinning, dry skin, constipation, a slow heart rate, low mood, pallor, brittle nails, shortness of breath, dizziness, or ice cravings. These suggest hypothyroidism or iron-deficiency anemia, both common and treatable. If you already take levothyroxine, mention the new symptom but do not change your dose yourself, since GLP-1 drugs can affect its absorption.
Does eating more protein actually help with feeling cold?
It addresses two of the underlying mechanisms. Protein has the highest thermic effect of any macronutrient, so it generates more heat during digestion than fat or carbohydrate, and adequate protein helps preserve heat-producing muscle during weight loss. Keeping a protein source in each meal — even small ones — is one of the more direct dietary levers for both comfort and lean-mass preservation on a GLP-1.
Related research
- Why GLP-1 medications cause fatigue — and how to manage it — the companion low-energy deep-dive; fatigue and cold intolerance share the calorie-deficit and metabolic-adaptation mechanisms.
- GLP-1, metabolism, energy expenditure, and brown fat — how these drugs change daily energy output and heat production at the tissue level.
- Eating too little on a GLP-1 — when the deficit becomes too aggressive, deepening metabolic adaptation and the cold, low-energy state.
- Thyroid labs and TSH monitoring on GLP-1 therapy — when and why to check thyroid function if cold intolerance and fatigue appear together.
- Iron deficiency, anemia, and ferritin on GLP-1 medications — the other treatable cause of cold intolerance, and how reduced intake can drive it.
- Levothyroxine and GLP-1 absorption — why thyroid-medication timing matters when gastric emptying slows.
References
- 1.Wilding JPH, Batterham RL, Calanna S, et al. (STEP 1 Study Group) Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021. PMID: 33567185.
- 2.Jastreboff AM, Aronne LJ, Ahmad NN, et al. (SURMOUNT-1 Study Group) Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022. PMID: 35658024.
- 3.Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995. PMID: 7632212.
- 4.Fothergill E, Guo J, Howard L, et al. Persistent metabolic adaptation 6 years after “The Biggest Loser” competition. Obesity (Silver Spring). 2016. PMID: 27136388.
- 5.Heilbronn LK, de Jonge L, Frisard MI, et al. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA. 2006. PMID: 16595757.
- 6.Westerterp KR. Diet induced thermogenesis. Nutr Metab (Lond). 2004. PMID: 15507147.
- 7.Chaston TB, Dixon JB, O'Brien PE. Changes in fat-free mass during significant weight loss: a systematic review. Int J Obes (Lond). 2007. PMID: 17075583.
- 8.Beard JL, Borel MJ, Derr J. Impaired thermoregulation and thyroid function in iron-deficiency anemia. Am J Clin Nutr. 1990. PMID: 2239756.
Important disclaimer. This article is educational and does not constitute medical advice. It is a plain-language summary of published clinical and physiological research and does not replace evaluation by a licensed clinician who knows your full medical history. Cold intolerance can be ordinary weight-loss physiology, but it can also signal hypothyroidism or iron-deficiency anemia, which require laboratory diagnosis and treatment. Do not start, stop, or change any medication, and do not self-diagnose or self-treat a suspected thyroid or iron problem, without professional guidance. Weight Loss Rankings does not provide medical advice, diagnosis, or treatment. Every primary source cited here was verified against the live PubMed E-utilities API on 2026-06-28.
Related research
Am I Eating Too Little on a GLP-1? An Evidence Guide
Appetite loss is the point of a GLP-1, but there's a floor. The real risks of chronic under-eating, the "starvation mode" truth, and a minimum-intake plan.
11 min read
Do GLP-1 Drugs Speed Up or Slow Your Metabolism?
Does Ozempic boost or slow your metabolism? The evidence: GLP-1 weight loss is driven by eating less, not burning more. Resting energy expenditure doesn't rise — it falls with weight loss (metabolic adaptation), and the brown-fat theory is unproven in humans.
10 min read
Ozempic and Thyroid Cancer: What the Boxed Warning Actually Means (2026)
Ozempic's boxed warning for thyroid C-cell tumors is based on rodent data — human relevance is undetermined and no causal link to thyroid cancer is established in people. What it means, who's contraindicated (MTC/MEN 2), the mixed human evidence, and symptoms to watch.
9 min read
GLP-1 + Thyroid Labs: TSH Changes and Monitoring Protocol
GLP-1 weight loss commonly drops TSH by 0.5-1.0 mIU/L without affecting fT4 — patients on levothyroxine often need dose adjustment. We review the published thyroid PK data, MTC boxed warning, and the quarterly monitoring protocol.
12 min read
GLP-1 Medications and Levothyroxine
The FDA pharmacokinetic interaction study with semaglutide tablets reported a 33% increase in total thyroxine AUC after a single 600 mcg levothyroxine dose. That finding is written verbatim into the Wegovy Section 7.2 (90% CI 1.25-1.42) and Rybelsus Sections 7.2 + 12.3.
11 min read
Can You Donate Blood on a GLP-1?
Taking a GLP-1 like Ozempic or Mounjaro generally won't bar you from donating blood. What actually matters: weight, hemoglobin, hydration, feeling well.
8 min read
Where to get GLP-1: vetted providers
Vetted telehealth providers that prescribe online, ranked by our editorial score. We compare pricing, form, and states served.
No insurance needed · vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Telos Rx
Needle-free and microdosed compounded GLP-1 options with lab-monitored care
Pricing Compare
Get started →Strut Health
Oral-lozenge compounded GLP-1 access
Pricing Compare
Get started →Live Vital
Shoppers who want low-cost, physician-led compounded GLP-1 with peptide and hormone options
Pricing Compare
Get started →